iX Biopharma Ltd. said on May, 12 2026 that it has allotted and issued 344,000 new ordinary shares following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share. The company’s issued share capital has risen to 1,051,239,596 shares from 1,050,895,596 shares.

The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around May, 14 2026.

To date, 20,480,151 warrants—representing 35.61% of the total originally issued—have been exercised. There remain 37,029,328 outstanding warrants, each exercisable at 0.06 Singapore dollars and expiring on Jul, 18 2026.

Warrant holders can find exercise instructions at the company’s website.